European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

Author:

Stratigos Alexander J.,Garbe Claus,Dessinioti Clio,Lebbe Celeste,Bataille Veronique,Bastholt Lars,Dreno Brigitte,Concetta Fargnoli Maria,Forsea Ana M.,Frenard Cecille,Harwood Catherine A.,Hauschild Axel,Hoeller Christoph,Kandolf-Sekulovic Lidija,Kaufmann Roland,Kelleners-Smeets Nicole W.J.,Malvehy Josep,del Marmol Veronique,Middleton Mark R.,Moreno-Ramirez David,Pellecani Giovanni,Peris Ketty,Saiag Philippe,van den Beuken-van Everdingen Marieke H.J.,Vieira Ricardo,Zalaudek Iris,Eggermont Alexander M.M.,Grob Jean-Jacques

Funder

EADO

Novartis

NeraCare

BMS

Roche

Sanofi

Bristol-Myers Squibb

Fabre

Almirall

Leo Pharma

AbbVie

Galderma

Merck

Pfizer

Meda

PellePharm

Ceries

Pierre Fabre

Sun Pharma

Merck Serono

Sanofi-Aventis

Regeneron

MSD/Merck

Philogen

Amgen

Biontech

Celgene

Janssen

Leo

Lilly

MSD

Wyeth

Netherlands Organization for Health Research and Development

ISDIN

GSK

Cantabria

AstraZeneca

Immunocore

Eisai

Millennium

Vertex

TC Biopharm

BioLineRx

Replimune

Modena and Reggio Emilia

Biogen Celgene

Roche-Genentech

Mylan

Difa Cooper

Cieffe Labs

La Roche Posay

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference133 articles.

1. Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. In: Group OLoEW, editor. The Oxford Levels of Evidence 2: Oxford Center for Evifdence-Based Medicine. https://www.cebm.net/index.aspx?o=5653. [Accessed23 April 2019].

2. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors;Brougham;J Surg Oncol,2012

3. Cetuximab-radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma;Joseph;J Med Imaging Radiat Oncol,2019

4. Advanced cutaneous squamous cell carcinoma: a retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG;Hillen;Eur J Cancer,2018

5. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study;Brantsch;Lancet Oncol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3